Professor Kelly Chibale
The Zambian-born chemist has been recognized for his work as the founder and director of the continent’s first integrated drug discovery centre at the University of Cape Town (UCT) in South Africa. The centre, known as H3D, was established in 2011 and its main focus is to combat malaria and TB. For Chibale, the ultimate goal is to create drugs that will overcome the resistance which is developing to earlier generations of drugs. He hopes to see Africa contribute to medical research beyond just offering the opportunity for clinical trials.